Increased expression of cathepsins and obesity-induced proinflammatory cytokines in lacrimal glands of male NOD mouse.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Investigative Ophthalmology and Visual Science

• Publication date

  2010-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1167/iovs.09-4523PMID 20463324PMCID PMC3066616
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lymphocytic infiltration leads to degradation of lacrimal gland extracellular matrix structures in NOD mice exhibiting a Sjögren's syndrome-like exocrinopathy.

  2010cited by this paper
• Altered expression of genes functioning in lipid homeostasis is associated with lipid deposition in NOD mouse lacrimal gland.

  2009cited by this paper
• Suppression of Lymphocyte Proliferation and Regulation of Dendritic Cell Phenotype by Soluble Mediators from Rat Lacrimal Epithelial Cells

  2009cited by this paper
• Increased degradation of extracellular matrix structures of lacrimal glands implicated in the pathogenesis of Sjögren's syndrome.

  2008cited by this paper
• Association between interleukin-15 and obesity: interleukin-15 as a potential regulator of fat mass.

  2008cited by this paper
• Cysteine cathepsins: cellular roadmap to different functions.

  2008cited by this paper
• Cathepsins: fundamental effectors of endolysosomal proteolysis.

  2008cited by this paper
• Regulation of inflammation‐related genes in human adipose tissue

  2007cited by this paper
• Lysosomal Cysteine Proteinase Cathepsin S as a Potential Target for Anti-Cancer Therapy

  2007cited by this paper
• Adipose tissue macrophages.

  2007cited by this paper
• Emerging roles of cysteine cathepsins in disease and their potential as drug targets.

  2007cited by this paper
• Unique Ultrastructure of Exorbital Lacrimal Glands in Male NOD and BALB/c Mice

  2006cited by this paper
• Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors

  2006cited by this paper
• Weight loss reduces adipose tissue cathepsin S and its circulating levels in morbidly obese women.

  2006cited by this paper
• Lipid microarrays identify key mediators of autoimmune brain inflammation

  2006cited by this paper
• Role of macrophage tissue infiltration in metabolic diseases

  2005cited by this paper
• Accumulation of Catalytically Active Proteases in Lacrimal Gland Acinar Cell Endosomes During Chronic Ex Vivo Muscarinic Receptor Stimulation

  2005cited by this paper
• Cathepsin S, a novel biomarker of adiposity: relevance to atherogenesis

  2005cited by this paper
• Cathepsin S Controls MHC Class II-Mediated Antigen Presentation by Epithelial Cells In Vivo1

  2005cited by this paper
• Two-dimensional liquid chromatography study of the human whole saliva proteome.

  2004cited by this paper
• Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans.

  2004cited by this paper
• Characterization of Murine Cathepsin W and Its Role in Cell-mediated Cytotoxicity*

  2004cited by this paper
• Resistin release by human adipose tissue explants in primary culture.

  2003cited by this paper
• Obesity is associated with macrophage accumulation in adipose tissue.

  2003cited by this paper
• Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis.

  2003cited by this paper
• Human Cathepsin H: Deletion of the Mini-Chain Switches Substrate Specificity from Aminopeptidase to Endopeptidase

  2003cited by this paper
• Antibodies to sulfatide in cerebrospinal fluid of patients with multiple sclerosis.

  2003cited by this paper
• Pathogenesis of Sjögren's syndrome: characteristics of different mouse models for autoimmune exocrinopathy.

  2002cited by this paper
• Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity.

  2002cited by this paper
• Effects of interleukin-15 (IL-15) on adipose tissue mass in rodent obesity models: evidence for direct IL-15 action on adipose tissue.

  2002cited by this paper
• Expression of cathepsins B and S in the progression of prostate carcinoma

  2001cited by this paper
• Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice.

  1999cited by this paper
• Self glycolipids as T‐cell autoantigens

  1999cited by this paper
• MR features of the lacrimal gland in Sjögren's syndrome.

  1998cited by this paper
• Male gonadal environment paradoxically promotes dacryoadenitis in nonobese diabetic mice.

  1998cited by this paper
• Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis

  1998cited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Expression of Somatostatin Receptor SST4 in Human Placenta and Absence of Octreotide Effect on Human Placental Growth Hormone Concentration during

  1997cited by this paper
• Premature fat deposition in the salivary glands associated with Sjögren syndrome: MR and CT evidence.

  1997cited by this paper
• Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice.

  1995cited by this paper
• Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.

  1995cited by this paper
• Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

  1993cited by this paper
• Monoclonal autoantibodies derived from multiple sclerosis patients and control persons and their reactivities with antigens of the central nervous system.

  1989cited by this paper
• Amino acid sequences of the human kidney cathepsins H and L

  1988cited by this paper
• Evidence of functional lymphocytes in some (leaky) scid mice

  1988cited by this paper
• Breeding of a non-obese, diabetic strain of mice.

  1980cited by this paper
• Cathepsin H: an endoaminopeptidase from rat liver lysosomes.

  1977cited by this paper

• Cathepsin H as a causal risk factor and therapeutic target in proliferative diabetic retinopathy

  2026cites this paper
• The Complex Roles of Macrophages in Sjögren’s Syndrome: A Narrative Review

  2025cites this paper
• Serum and tear autoantibodies from NOD and NOR mice as potential diagnostic indicators of local and systemic inflammation in Sjögren’s disease

  2025cites this paper
• Tear Fluid Derived Extracellular Vesicles for New Biomarker Discovery.

  2025cites this paper
• Multi-omics analysis reveals that low cathepsin S expression aggravates sepsis progression and worse prognosis via inducing monocyte polarization

  2025cites this paper
• Non-Canonical, Extralysosomal Activities of Lysosomal Peptidases in Physiological and Pathological Conditions: New Clinical Opportunities for Cancer Therapy

  2025cites this paper
• Cathepsin H deficiency leads to myopic phenotype in mice.

  2025cites this paper
• IL-37 Inhibits Inflammation of Lacrimal Gland in Dry Eye Mice via the IL-37-PTEN-NFκB Signaling Pathway

  2024cites this paper
• Inhibition of mTOR differently modulates planar and subepithelial fibrogenesis in human conjunctival fibroblasts

  2024cites this paper
• Cathepsin S Knockdown Suppresses Endothelial Inflammation, Angiogenesis, and Complement Protein Activity under Hyperglycemic Conditions In Vitro by Inhibiting NF-κB Signaling

  2023cites this paper
• Identification of the shared mechanisms and common biomarkers between Sjögren’s syndrome and atherosclerosis using integrated bioinformatics analysis

  2023cites this paper
• Effects of Cathepsin S Inhibition in the Age-Related Dry Eye Phenotype

  2023cites this paper
• Cathepsin S inhibition in dendritic cells prevents Th17 cell differentiation in perivascular adipose tissues following vascular injury in diabetic rats

  2023cites this paper
• Reviewof genes potentially related to hyposecretion in male non-obese diabetic (NOD)mice, a Sjögren's syndrome model.

  2023cites this paper
• The miRNA Landscape of Lacrimal Glands in a Murine Model of Autoimmune Dacryoadenitis

  2023cites this paper
• The neuroimmune axis of Alzheimer’s disease

  2023cites this paper
• Cathepsin S (CTSS) activity in health and disease - A treasure trove of untapped clinical potential.

  2022cites this paper
• Defining the Role of Monocytes in Sjögren’s Syndrome

  2022cites this paper
• Proteases and Their Potential Role as Biomarkers and Drug Targets in Dry Eye Disease and Ocular Surface Dysfunction

  2022influential citation
• Mucopolysaccharidosis Type IVA: Extracellular Matrix Biomarkers in Cardiovascular Disease

  2022cites this paper
• The ocular surface immune system through the eyes of aging.

  2021cites this paper
• Cathepsin S is a novel target for age-related dry eye.

  2021cites this paper
• Tear miRNAs Identified in a Murine Model of Sjögren’s Syndrome as Potential Diagnostic Biomarkers and Indicators of Disease Mechanism

  2021influential citation
• Phenylephrine increases tear cathepsin S secretion in healthy murine lacrimal gland acinar cells through an alternative secretory pathway.

  2021cites this paper
• Association of Circulating Cathepsin S and Cardiovascular Disease Among Patients With Type 2 Diabetes: A Cross-Sectional Community-Based Study

  2021cites this paper
• Oculoplastic surgical simulation using goat sockets

  2021cites this paper
• Rapamycin Eyedrops Increased CD4+Foxp3+ Cells and Prevented Goblet Cell Loss in the Aged Ocular Surface

  2020cites this paper
• Tear Proteases and Protease Inhibitors: Potential Biomarkers and Disease Drivers in Ocular Surface Disease.

  2020cites this paper
• Cathepsin S activation contributes to elevated CX3CL1 (fractalkine) levels in tears of a Sjögren’s syndrome murine model

  2020cites this paper
• Small RNA Deep Sequencing Identifies a Unique miRNA Signature Released in Serum Exosomes in a Mouse Model of Sjögren's Syndrome

  2020cites this paper
• Arginase 1 is involved in lacrimal hyposecretion in male NOD mice, a model of Sjögren's syndrome, regardless of dacryoadenitis status

  2020cites this paper
• Modulation of Oxidative Stress and Inflammation in the Aged Lacrimal Gland.

  2020cites this paper
• Lysosomes as a therapeutic target

  2019cites this paper
• Berunda Polypeptides: Biheaded Rapamycin Carriers for Subcutaneous Treatment of Autoimmune Dry Eye Disease.

  2019cites this paper
• Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren’s Syndrome

  2019cites this paper
• Human umbilical cord mesenchymal stem cells alleviate ongoing autoimmune dacryoadenitis in rabbits via polarizing macrophages into an anti-inflammatory phenotype.

  2019cites this paper
• Targeting primary Sjögren’s syndrome

  2019cites this paper
• First-in-human study of the safety and viability of intraocular robotic surgery

  2018cites this paper
• Increased Cathepsin S activity associated with decreased protease inhibitory capacity contributes to altered tear proteins in Sjögren’s Syndrome patients

  2018cites this paper
• Cathepsin S Alters the Expression of Pro-Inflammatory Cytokines and MMP-9, Partially through Protease—Activated Receptor-2, in Human Corneal Epithelial Cells

  2018cites this paper
• Longitudinal analysis of tear cathepsin S activity levels in male non-obese diabetic mice suggests its potential as an early stage biomarker of Sjögren’s Syndrome

  2018cites this paper
• NOD and NOR mice exhibit comparable development of lacrimal gland secretory dysfunction but NOD mice have more severe autoimmune dacryoadenitis

  2018cites this paper
• Molecular Regulatory Mechanism of Exocytosis in the Salivary Glands

  2018cites this paper
• Impact of obesity on autoimmune arthritis and its cardiovascular complications.

  2018cites this paper
• Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren’s Syndrome

  2017cites this paper
• Cornea Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren ’ s Syndrome

  2017influential citation
• Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome

  2017cites this paper
• Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Tear Production in a Mouse Model of Sjögren's Syndrome

  2017cites this paper
• A mechanistic target of rapamycin complex 1/2 (mTORC1)/V-Akt murine thymoma viral oncogene homolog 1 (AKT1)/cathepsin H axis controls filaggrin expression and processing in skin, a novel mechanism for skin barrier disruption in patients with atopic dermatitis

  2017cites this paper
• Proteases in Physiology and Pathology

  2017cites this paper
• Myeloid Populations in Systemic Autoimmune Diseases

  2017cites this paper
• Physiological and Pathological Functions of Cysteine Cathepsins

  2017cites this paper
• Imbalanced Rab3D versus Rab27 increases cathepsin S secretion from lacrimal acini in a mouse model of Sjögren's Syndrome.

  2016cites this paper
• Symbiotic gut commensal bacteria act as host cathepsin S activity regulators.

  2016cites this paper
• Biomedical Applications of Recombinant Proteins and Derived Polypeptides

  2016cites this paper
• Sjögren ' s Syndrome secretion from lacrimal acini in a mouse model of Imbalanced Rab 3 D versus Rab 27 increases cathepsin

  2016cites this paper
• Imbalanced Rab 3 D versus Rab 27 increases cathepsin S secretion from lacrimal acini in a mouse model of Sjögren ’ s Syndrome

  2016cites this paper
• Manipulating Autophagic Processes in Autoimmune Diseases: A Special Focus on Modulating Chaperone-Mediated Autophagy, an Emerging Therapeutic Target

  2015cites this paper
• Cytoplasmic and nuclear leptin expression in lacrimal gland tumours: a pilot study

  2015cites this paper
• The Toll of too much Interferon

  2015cites this paper
• The Toll of too much Interferon : The systemic interferon signature in the pathogenesis of Sjögren’s syndrome

  2015cites this paper
• Cathepsin S: therapeutic, diagnostic, and prognostic potential

  2015cites this paper
• The Roles of Lysosomes in Inflammation and Autoimmune Diseases

  2015cites this paper
• The clinical relevance of animal models in Sjögren’s syndrome: the interferon signature from mouse to man

  2015cites this paper
• In vivo imaging models for testing the inflammatory potential of implant materials and infection

  2015cites this paper
• Macrophages: important players in primary Sjögren’s syndrome?

  2014cites this paper
• Narcolepsy is a sleep disorder associated with polymorphisms in genes involved in immune response

  2014cites this paper
• Tear Cathepsin S as a Candidate Biomarker for Sjögren's Syndrome

  2014cites this paper
• ImmunoChip Study Implicates Antigen Presentation to T Cells in Narcolepsy

  2013cites this paper
• Chapter 413 – Cathepsin S

  2013cites this paper
• ImmunoChip Study Implicates Antigen Presentation to T Cells in Narcolepsy

  2013cites this paper
• Correlation between serum cathepsin S and insulin resistance in type 2 diabetes

  2013cites this paper
• A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjögren's syndrome.

  2013cites this paper
• Chapter 408 – Cathepsin H

  2013cites this paper
• Subcloning and Expression of Functional Human Cathepsin B and K in E. coli: Characterization and Inhibition by Flavonoids

  2011cites this paper
• Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome

  2011cites this paper
• Dysfunction of Lacrimal and Salivary Glands in Sjögren's Syndrome: Nonimmunologic Injury in Preinflammatory Phase and Mouse Model

  2011cites this paper